This 2022 review explores the applications of extracorporeal shock wave therapy (ESWT) in oncology, encompassing in vitro studies, animal models, and clinical rehabilitation. The article discusses ESWT's potential to enhance the cytotoxic effects of chemotherapeutic agents like doxorubicin and methotrexate on osteosarcoma cell lines, as well as its role in
